Lung cancer screening for Asian and Latinx communities
Part of Cancer, Lungs & breathing clinical trials.
This study uses a blood test to look for signs of lung cancer in people who have never smoked or smoked very little. It focuses on Asian and Latinx communities because certain gene changes are more common in these groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old and have never smoked or smoked fewer than 20 packs in your life.
- You identify as East Asian, Southeast Asian, or Hispanic/Latinx.
- Or you are between 40 and 49 years old with certain risk factors like a family history of lung cancer, a past cancer that was cured more than 5 years ago, or recent lung symptoms.
- You have not had a chest CT scan in the last 3 years or plan to have one soon.
- You have not had cancer (other than minor skin cancer) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why certain EGFR-positive advanced lung cancers resist third-generation EGFR tablet treatment given as the first treatment. Your body samples and scan results help researchers understand the resistance, which may guide better future care.
This study tests whether using a blood test to detect leftover tumor DNA after surgery can guide extra treatment for people with EGFR-mutant lung cancer. The goal is to see if starting or avoiding targeted therapy based on this test improves outcomes.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study tests whether combining low-dose chest CT scans with blood “biomarker” tests can help find lung cancer earlier in people at higher risk. You may be asked to have scans and blood tests and then attend follow-up visits over time.
This study is testing a new way to help find lung cancer earlier by combining imaging (like CT scans) with a blood test that looks at DNA changes. If you have lung cancer and haven't started treatment yet, participating may help improve future detection methods.
This study uses leftover tissue or fluid from your lung cancer to test how it responds to different drugs in the lab. The goal is to understand which treatments might work best for tumors with EGFR mutations, which could help guide future treatment decisions.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.